Bio-Path Holdings, Inc. Press Releases

BPTH 
$2.31
*  
0.03
1.32%
Get BPTH Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading BPTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing



Bio-Path Holdings Announces Research Collaboration on Autoimmune Indication with The University of Texas Southwestern Medical Center
3/23/2016 8:55:00 AM - Business Wire
▲10.00 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Path Holdings Reports Fiscal Year 2015 Operational and Financial Results
3/16/2016 8:55:00 AM - Business Wire
▲24.19 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Path Holdings Announces Pancreatic Cancer Research Collaboration with Leading Oncology Institution
3/8/2016 8:55:00 AM - Business Wire
▲35.88 % Price Change since this news event. The Volume Ratio is 46.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Path Holdings to Present at the 28th Annual ROTH Conference
3/7/2016 8:55:00 AM - Business Wire
▲45.28 % Price Change since this news event. The Volume Ratio is 0.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Path Holdings Announces Completion of the Safety Segment of the Phase II Clinical Trial of BP1001 in Acute Myeloid Leukemia
3/3/2016 8:55:00 AM - Business Wire
▲20.94 % Price Change since this news event. The Volume Ratio is 4.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bio-Path Holdings to Present at the 18th Annual BIO CEO & Investor Conference
2/1/2016 8:55:00 AM - Business Wire
▲65.00 % Price Change since this news event. The Volume Ratio is 0.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day